Related Experiment Video
Updated: May 28, 2026
04:24
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Fatigue in bronchiectasis
K L M Hester1, J G Macfarlane, H Tedd
1Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.
QJM : Monthly Journal of the Association of Physicians
|October 22, 2011
Summary
Fatigue in non-CF bronchiectasis correlates with breathlessness and lung function, but not Pseudomonas aeruginosa infection. Understanding these links is key for managing this disabling symptom.
Area of Science:
- Pulmonology
- Clinical Research
- Respiratory Medicine
Background:
- Fatigue is a significant and disabling symptom in non-CF bronchiectasis (nCF-Br).
- The validated Fatigue Impact Scale (FIS) can measure fatigue.
- The link between fatigue and disease severity markers like airflow obstruction, breathlessness, or Pseudomonas aeruginosa infection in nCF-Br is not well understood.
Purpose of the Study:
- To quantify the association between FIS scores and indicators of disease severity in nCF-Br patients.
- To explore correlations between fatigue and lung function, breathlessness, and P. aeruginosa status.
Main Methods:
- A prospective cohort study design was employed.
- 117 patients with nCF-Br were assessed for lung function (FEV(1)% predicted), Medical Research Council dyspnoea score (MRCD), and sputum culture for P. aeruginosa.
- Patients were grouped based on P. aeruginosa presence: 'colonization', 'isolation', or neither.
Main Results:
- Fatigue scores (FIS) showed significant correlations with MRCD scores (r=0.57, P<0.001) and FEV(1)% predicted (r=-0.30, P=0.001).
- Patients with a history of P. aeruginosa isolation or colonization had lower FEV(1)% predicted (P≤0.001).
- No significant association was found between P. aeruginosa status and fatigue levels (P=0.155 for colonization, P=0.31 for significant fatigue).
Conclusions:
- FIS scores are significantly correlated with breathlessness (MRCD) and airflow obstruction (FEV(1)% predicted) in non-CF bronchiectasis.
- While P. aeruginosa infection is linked to poorer lung function and increased breathlessness, it does not appear to significantly impact fatigue levels in this patient group.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...